Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA 2005 Budget Request Omits Boost For OTCs, Asks For CDER FTE Cutbacks

This article was originally published in The Tan Sheet

Executive Summary

FDA's fiscal 2005 budget request provides no new increase for over-the-counter drug activities

You may also be interested in...



2006 Budget Request Aims To Build Drug Safety; OTC Spending Likely Flat

The Bush Administration's fiscal 2006 budget request represents a shift in resources toward drug safety activities within the Center for Drug Evaluation & Research

2006 Budget Request Aims To Build Drug Safety; OTC Spending Likely Flat

The Bush Administration's fiscal 2006 budget request represents a shift in resources toward drug safety activities within the Center for Drug Evaluation & Research

2006 Budget Request Aims To Build Drug Safety; OTC Spending Likely Flat

The Bush Administration's fiscal 2006 budget request represents a shift in resources toward drug safety activities within the Center for Drug Evaluation & Research

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096451

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel